Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
rosiglitazone
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Generic mfg.
Drug class:
PPAR γ agonist
Related drugs:
‹
CS-7017 (0)
ABTL0812 (0)
CS-7017 (0)
ABTL0812 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
PPARG positive
Bladder Cancer
PPARG positive
Bladder Cancer
rosiglitazone
Sensitive: D – Preclinical
rosiglitazone
Sensitive
:
D
rosiglitazone
Sensitive: D – Preclinical
rosiglitazone
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login